Charles River Laboratories Intl. Inc (N:CRL)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 251 Ballardvale St
WILMINGTON MA 01887-1096
Tel: N/A
Website: https://www.criver.com
IR: See website
<
Key People
James C. Foster
Chairman of the Board, President, Chief Executive Officer
David Ross Smith
Chief Financial Officer, Corporate Executive Vice President
William D. Barbo
Corporate Executive Vice President and Chief Commercial Officer
Birgit Girshick
Corporate Executive Vice President, Global Discovery and Safety Assessment, Biologics and Avian
Joseph W. LaPlume
Corporate Executive Vice President, Corporate Development and Strategy
 
Business Overview
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.
Financial Overview
For the three months ended 27 March 2021, CharlesRiver Laboratories Intl. Inc revenues increased 17% to$824.6M. Net income increased 21% to $61.5M. Revenuesreflect Discovery And Safety Assessment segment increase of14% to $501.2M, Research Models segment increase of 21% to$176.9M, Manufacturing Support segment increase of 20% to$146.5M, Europe segment increase of 25% to $237.5M, UnitedStates segment increase of 10% to $448.5M.
Employees: 18,400 as of Dec 26, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $18,953M as of Mar 27, 2021
Annual revenue (TTM): $3,041M as of Mar 27, 2021
EBITDA (TTM): $722.61M as of Mar 27, 2021
Net annual income (TTM): $375.07M as of Mar 27, 2021
Free cash flow (TTM): $479.35M as of Mar 27, 2021
Net Debt Last Fiscal Year: $1,739M as of Mar 27, 2021
Shares outstanding: 50,252,814 as of Apr 23, 2021
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.